Centene Share Price (NYSE: CNC)

$29.04

▲

0.66

(2.33%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Centene Stock chart to analyse performance

Centene stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$28.37
Today's High:$29.08
$29.04
2.31%
Downside
Day's Volatility :2.44%
Upside
0.14%
52 Weeks Low:$25.08
52 Weeks High:$80.59
$29.04
13.65%
Downside
52 Weeks Volatility :68.89%
Upside
63.97%

Centene Stock Returns

Period	Centene Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-47.12%	3.6%	0.0%
6 Months	-50.44%	-7.7%	0.0%
1 Year	-63.81%	-12.6%	0.0%
3 Years	-68.18%	10.2%	-4.1%

Centene Corp. Key Stats

Check Centene key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$28.38
Open	$28.41
Today's High	$29.08
Today's Low	$28.37
Market Capitalization	$14.3B
Today's Volume	$8.3M
52 Week High	$80.59
52 Week Low	$25.075
Revenue TTM	$159.6B
EBITDA	$4.7B
Earnings Per Share (EPS)	$4.12
PE Ratio	7.05
Profit Margin	1.29%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	7.44%

Stock Returns calculator for Centene Stock including INR - Dollar returns

The Centene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Centene investment value today

Current value as on today

₹41,480

Returns

₹58,520

(-58.52%)

Returns from Centene Stock

₹63,804 (-63.8%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Centene Stock

-78.04%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Centene Shares from India has dropped by -78.04% over the past 30 days, indicating reduced transactional activity.

-49%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Centene Stock from India on INDmoney has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Centene Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	4022	-0.44	0.02%

Global Institutional Holdings in Centene Corp.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.89%
BlackRock Inc
9.20%
FMR Inc
5.42%
NORGES BANK
5.39%
State Street Corp
4.62%
Harris Associates L.P.
4.16%

Analyst Recommendation on Centene Stock

Rating

Trend

Buy

56%Buy

43%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Centene(by analysts ranked 0 to 5 stars)

Centene Share Price Target

What analysts predicted

Upside of 20.09%

Target:

$34.88

Current:

$29.04

Centene share price target is $34.88, a slight Upside of 20.09% compared to current price of $29.04 as per analysts' prediction.

Centene Stock Insights

Price Movement
In the last 3 months, CNC stock has moved down by -48.6%
Increasing Revenue
Revenue is up for the last 3 quarters, 40.80B → 48.74B (in $), with an average increase of 8.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.31B → -253.0M (in $), with an average decrease of 119.3% per quarter
CNC vs CVS (1 yr)
In the last 1 year, Cvs Health Corporation has given 27.8% return, outperforming this stock by 91.0%
CNC vs CI (3 yr)
In the last 3 years, Centene Corp. has experienced a drawdown of -67.6%, however The Cigna Corp resisted the overall trend and outperformed by 42.2%
Price to Sales
ForCNC every $1 of sales, investors are willing to pay $0.1, whereas for Cvs Health Corporation, the investors are paying $0.2 for every $1 of sales.

Centene Corp. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$74.6B	↑ 24.16%
Net Income	$1.3B	↑ 46.78%
Net Profit Margin	1.77%	↑ 0.27%

	FY20	Y/Y Change
Revenue	$111.1B	↑ 48.87%
Net Income	$1.8B	↑ 36.87%
Net Profit Margin	1.63%	↓ 0.14%

	FY21	Y/Y Change
Revenue	$126.0B	↑ 13.38%
Net Income	$1.3B	↓ 25.5%
Net Profit Margin	1.07%	↓ 0.56%

	FY22	Y/Y Change
Revenue	$144.5B	↑ 14.74%
Net Income	$1.2B	↓ 10.76%
Net Profit Margin	0.83%	↓ 0.24%

	FY23	Y/Y Change
Revenue	$154.0B	↑ 6.54%
Net Income	$2.7B	↑ 124.79%
Net Profit Margin	1.75%	↑ 0.92%

	FY24	Y/Y Change
Revenue	$163.1B	↑ 5.89%
Net Income	$3.3B	↑ 22.32%
Net Profit Margin	2.03%	↑ 0.28%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$40.4B	↑ 2.4%
Net Income	$1.2B	↑ 2484.44%
Net Profit Margin	2.88%	↑ 2.77%

	Q2 FY24	Q/Q Change
Revenue	$39.8B	↓ 1.41%
Net Income	$1.1B	↓ 1.46%
Net Profit Margin	2.88%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$42.0B	↑ 5.49%
Net Income	$713.0M	↓ 37.78%
Net Profit Margin	1.7%	↓ 1.18%

	Q4 FY24	Q/Q Change
Revenue	$40.8B	↓ 2.9%
Net Income	$283.0M	↓ 60.31%
Net Profit Margin	0.69%	↓ 1.01%

	Q1 FY25	Q/Q Change
Revenue	$46.6B	↑ 14.25%
Net Income	$1.3B	↑ 363.25%
Net Profit Margin	2.81%	↑ 2.12%

	Q2 FY25	Q/Q Change
Revenue	$48.7B	↑ 4.55%
Net Income	$-253.0M	↓ 119.3%
Net Profit Margin	-0.52%	↓ 3.33%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$8.8B	↑ 5.01%

	FY20	Y/Y Change
Profit	$15.2B	↑ 72.07%

	FY21	Y/Y Change
Profit	$14.2B	↓ 6.68%

	FY22	Y/Y Change
Profit	$16.7B	↑ 17.3%

	FY23	Y/Y Change
Profit	$31.5B	↑ 89.37%

	FY24	Y/Y Change
Profit	$16.8B	↓ 46.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.6B	↑ 26.91%

	Q2 FY24	Q/Q Change
Profit	$4.4B	↓ 4.65%

	Q3 FY24	Q/Q Change
Profit	$4.0B	↓ 8.9%

	Q4 FY24	Q/Q Change
Profit	$3.7B	↓ 7.81%

	Q1 FY25	Q/Q Change
Profit	$5.2B	↑ 39.84%

	Q2 FY25	Q/Q Change
Profit	$2.9B	↓ 43.35%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.5B	↑ 20.18%
Investing Cash Flow	$-1.5B	↓ 66.59%
Financing Cash Flow	$6.8B	↑ 48.14%

	FY20	Y/Y Change
Operating Cash Flow	$5.5B	↑ 271.07%
Investing Cash Flow	$-7.0B	↑ 353.98%
Financing Cash Flow	$260.0M	↓ 96.19%

	FY21	Y/Y Change
Operating Cash Flow	$4.2B	↓ 23.59%
Investing Cash Flow	$-3.3B	↓ 52.57%
Financing Cash Flow	$1.4B	↑ 423.85%

	FY22	Y/Y Change
Operating Cash Flow	$6.3B	↑ 48.89%
Investing Cash Flow	$-2.9B	↓ 11.46%
Financing Cash Flow	$-4.2B	↓ 408.15%

	FY23	Y/Y Change
Operating Cash Flow	$8.1B	↑ 28.62%
Investing Cash Flow	$-1.2B	↓ 59.23%
Financing Cash Flow	$-1.7B	↓ 60.5%

	FY24	Y/Y Change
Operating Cash Flow	$154.0M	↓ 98.09%
Investing Cash Flow	$-1.1B	↓ 11.67%
Financing Cash Flow	$-2.4B	↑ 45.11%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q2 FY24	Q/Q Change
Operating Cash Flow	$2.2B	↓ 576.97%
Investing Cash Flow	$-1.2B	-
Financing Cash Flow	$-1.2B	↓ 5191.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-978.0M	↓ 144.97%
Investing Cash Flow	$-839.0M	↓ 28.11%
Financing Cash Flow	$-1.2B	↑ 6.32%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-587.0M	↓ 39.98%
Investing Cash Flow	$102.0M	↓ 112.16%
Financing Cash Flow	$-13.0M	↓ 98.96%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$1.5B	↓ 357.24%
Investing Cash Flow	$-529.0M	↓ 618.63%
Financing Cash Flow	$-250.0M	↑ 1823.08%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.8B	↑ 18.21%
Investing Cash Flow	$-899.0M	↑ 69.94%
Financing Cash Flow	$-1.2B	↑ 369.6%

Centene Technicals Summary

Sell

Neutral

Buy

Centene is currently in a neutral trading position according to technical analysis indicators.

Centene Corp. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Centene Corp.	12.06%	-50.44%	-63.81%	-68.18%	-52.69%
The Cigna Corp	14.77%	-3.39%	-17.65%	4.49%	70.85%
Cvs Health Corporation	17.14%	12.76%	27.54%	-26.77%	21.4%
Humana Inc.	22.81%	16.11%	-16.47%	-37.64%	-26.8%
Elevance Health, Inc	16.03%	-19.42%	-43.32%	-34.99%	16.7%
Unitedhealth Group Incorporated	30.33%	-33.65%	-48.24%	-40.86%	-0.94%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Centene Corp.	7.05	7.05	1.49	1.62	0.07	0.03	NA	55.8
The Cigna Corp	16.39	16.39	0.59	29.66	0.13	0.04	0.02	150.84
Cvs Health Corporation	20.09	20.09	0.75	6.31	0.06	0.02	0.04	61.07
Humana Inc.	23.25	23.25	1.01	16.93	0.09	0.05	0.01	151.61
Elevance Health, Inc	13.18	13.18	0.84	30.02	0.12	0.05	0.02	194.46
Unitedhealth Group Incorporated	13.09	13.09	1.24	16.22	0.22	0.06	0.03	104.67

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Centene Corp.	Buy	$14.3B	-52.69%	7.05	1.29%
The Cigna Corp	Buy	$80.1B	70.85%	16.39	1.92%
Cvs Health Corporation	Buy	$91.5B	21.4%	20.09	1.18%
Humana Inc.	Buy	$36.5B	-26.8%	23.25	1.28%
Elevance Health, Inc	Buy	$69.9B	16.7%	13.18	2.83%
Unitedhealth Group Incorporated	Buy	$273.8B	-0.94%	13.09	5.04%

About Centene Corp.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Organization	Centene
Employees	60500
CEO	Ms. Sarah M. London
Industry	Health Services

Key Management of Centene Corp.

Name	Title
Ms. Sarah M. London	CEO & Director
Mr. Andrew Lynn Asher	Chief Financial Officer
Ms. Susan R. Smith	Chief Operating Officer
Mr. Christopher Andrew Koster	Executive VP, General Counsel & Secretary
Ms. Katie Nicole Casso	Senior Vice President of Finance, Corporate Controller and Chief Accounting Officer
Mr. Brian Phillip LeClaire M.B.A., Ph.D.	Chief Information Officer
Ms. Jennifer Lynch Gilligan	Senior Vice President of Investor Relations
Ms. Ashlee Knuckey	Chief Risk, Ethics & Compliance Officer
Ms. Tanya M. McNally	Senior VP & Chief People Officer
Ms. Cary D. Hobbs	Executive VP & Chief of Staff

Important FAQs about investing in CNC Stock from India :

What is Centene share price today?

Centene share price today is $29.04 as on August 30, 2025 at 1:29 am IST at the close of the market. Centene share today touched a day high of $29.08 and a low of $28.37.

What is the 52 week high and 52 week low for Centene share?

Centene share touched a 52 week high of $80.59 and a 52 week low of $25.08. Centene stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $29.04, lower by 63.97% versus the 52 week high.

How to invest in Centene Stock (CNC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Centene on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centene Shares that will get you 0.0517 shares as per Centene share price of $29.04 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Centene Stock (CNC) from India?

Indian investors can start investing in Centene (CNC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Centene stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Centene share’s latest price of $29.04 as on August 30, 2025 at 1:29 am IST, you will get 0.3444 shares of Centene. Learn more about fractional shares .

What are the returns that Centene has given to Indian investors in the last 5 years?

Centene stock has given -52.69% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?